Yang Dajun 4

What Happened

• Dajun Yang, Chairman & CEO (and Director) of Ascentage Pharma Group International (AAPG), was granted multiple restricted stock units (RSUs) on 05/20/2026 totaling 1,421,426 RSUs. Per the filing, those RSUs vested on 05/21/2026 and converted into ordinary shares (each RSU converts to one share).
• The reported transactions show the conversions/exercises and indicate no cash paid or received (all reported at $0.00). Two tranches — 95,575 and 92,746 shares — are shown as both converted and disposed on 05/21/2026 (reported at $0), consistent with transfers or distributions rather than a market sale.

Key Details

• Transaction dates and prices: RSU grants on 05/20/2026; RSU vesting/conversion on 05/21/2026. All transactions reported at $0.00 (no cash exchanged).
• Total RSUs granted on 05/20/2026: 1,421,426 (various tranches listed in the filing).
• Reported immediate dispositions: 95,575 and 92,746 shares converted and shown as disposed on 05/21/2026 (both at $0).
• Footnotes of note:
  • F4/F10: RSUs represent a right to one ordinary share on vesting; they vested on 05/21/2026 and have no expiration.
  • F5/F11: Some RSUs represent grants to the reporting person and to the reporting person’s spouse; F11 confirms spouse’s RSUs vested in full on 05/21/2026.
  • F1–F3: Certain shares are held by the Dajun Yang Dynasty Trust, by the reporting person’s spouse, or entities controlled by the spouse; the reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
• Shares owned after transaction: Not specified in the provided excerpt; consult the full Form 4 for post-transaction holdings.
• Filing timeliness: Form filed 05/22/2026 for transactions dated 05/20–05/21/2026 (filed within the typical two-business-day window).

Context

• These were RSU vesting and conversions (derivative transactions). Because the reported price is $0.00, this reflects vesting/conversion of awarded units rather than a cash purchase or open-market sale.
• The presence of immediate dispositions (at $0) usually indicates transfers (for example to spouse or trust) or other non-cash movements — not necessarily a market sale. The filing’s footnotes clarify related-party holdings and disclaimers.
• No cash purchases or open-market sales were reported; purchases (bullish signal) are generally more informative than routine vesting/transfer events.